These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10755549)

  • 1. In vivo T-cell depletion enhances production of anti-GALalpha1,3GAL natural antibodies in alpha1,3-galactosyltransferase-deficient mice.
    Ohdan H; Yang YG; Swenson KG; Thall AD; Sykes M
    Transplantation; 2000 Mar; 69(5):910-3. PubMed ID: 10755549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mac-1-negative B-1b phenotype of natural antibody-producing cells, including those responding to Gal alpha 1,3Gal epitopes in alpha 1,3-galactosyltransferase-deficient mice.
    Ohdan H; Swenson KG; Kruger Gray HS; Yang YG; Xu Y; Thall AD; Sykes M
    J Immunol; 2000 Nov; 165(10):5518-29. PubMed ID: 11067905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells.
    Kawahara T; Ohdan H; Zhao G; Yang YG; Sykes M
    J Immunol; 2003 Nov; 171(10):5406-14. PubMed ID: 14607944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerization of Gal alpha 1,3Gal-reactive B cells in pre-sensitized alpha 1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism.
    Ohdan H; Swenson KG; Kitamura H; Yang YG; Sykes M
    Xenotransplantation; 2001 Nov; 8(4):227-38. PubMed ID: 11737848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism.
    Yang YG; deGoma E; Ohdan H; Bracy JL; Xu Y; Iacomini J; Thall AD; Sykes M
    J Exp Med; 1998 Apr; 187(8):1335-42. PubMed ID: 9547344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism.
    Ohdan H; Yang YG; Swenson KG; Kitamura H; Sykes M
    Transplantation; 2001 Jun; 71(11):1532-42. PubMed ID: 11435961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of anti-Gal alpha 1-3Gal natural antibodies in sera of alpha 1,3-galactosyltransferase-deficient mice receiving Gal-positive bone marrow transplantation.
    Ohdan H; Yang YG; Sykes M
    Transplant Proc; 1999; 31(1-2):945-6. PubMed ID: 10083418
    [No Abstract]   [Full Text] [Related]  

  • 8. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection.
    Ohdan H; Yang YG; Shimizu A; Swenson KG; Sykes M
    J Clin Invest; 1999 Aug; 104(3):281-90. PubMed ID: 10430609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the Gal alpha1-3 Gal antigen in discordant islet xenotransplantation: immunosuppression, which inhibits porcine islet xenograft rejection in ordinary mice, is equally effective in Gal-knockout mice.
    Wennberg L; Song Z; Bennet W; Sandberg JO; Sundberg B; Thall A; Korsgren O
    Transplantation; 2004 Apr; 77(8):1275-80. PubMed ID: 15114098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cytolytic anti-Gal antibodies in alpha-1,3-galactosyltransferase gene knockout mice by oral inoculation with Escherichia coli O86:B7 bacteria.
    Posekany KJ; Pittman HK; Bradfield JF; Haisch CE; Verbanac KM
    Infect Immun; 2002 Nov; 70(11):6215-22. PubMed ID: 12379700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exploratory investigation of the effect of arsenic trioxide on anti-Gal antibody production in baboons.
    Gollackner B; Ryan D; Knosalla C; Basker M; Alwayn IP; Harper D; Salomon G; Mauiyyedi S; Correa L; Thall A; Cooper DK
    Xenotransplantation; 2003 Jan; 10(1):80-7. PubMed ID: 12535229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Gal antibodies in humans and 1, 3alpha-galactosyltransferase knock-out mice.
    Chiang TR; Fanget L; Gregory R; Tang Y; Ardiet DL; Gao L; Meschter C; Kozikowski AP; Buelow R; Vuist WM
    Transplantation; 2000 Jun; 69(12):2593-600. PubMed ID: 10910282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The resistance of delayed xenograft rejection to alpha(1,3)-galactosyltransferase gene inactivation and CD4 depletion in a mouse-to-rat model.
    Hansen AB; Kirkeby S; Aasted B; Dahl K; Hansen AK; Dieperink H; Svendsen M; Kemp E; Buschard K; D'Apice AJ
    APMIS; 2003 Nov; 111(11):1019-26. PubMed ID: 14629268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection.
    Yin DP; Sankary HN; Ma LL; Shen J; Qin Y; Blinder L; Williams JW; Chong AS
    Transplantation; 2001 May; 71(10):1385-9. PubMed ID: 11391223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of anti-Gal B cell receptor transgenic Gal-/- mice.
    Xu H; Sharma A; Lei Y; Okabe J; Wan H; Chong AS; Logan JS; Byrne GW
    Transplantation; 2002 May; 73(10):1549-57. PubMed ID: 12042639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.
    Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Nomoto K; Tominaga R
    Scand J Immunol; 2006 Jun; 63(6):435-43. PubMed ID: 16764697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of cyclophosphamide-induced tolerance in alpha1,3-galactosyltransferase knockout mice presensitized with Gal alpha 1-3Gal beta-4-GlcNAc antigens.
    Onzuka T; Shimizu I; Tomita Y; Iwai T; Okano S; Tominaga R
    Surg Today; 2008; 38(9):807-14. PubMed ID: 18751946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of natural IgM binding and complement activation by natural IgG antibodies: a role for IgG anti-Gal alpha1-3Gal antibodies.
    Yu PB; Holzknecht ZE; Bruno D; Parker W; Platt JL
    J Immunol; 1996 Dec; 157(11):5163-8. PubMed ID: 8943428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells.
    Saethre M; Baumann BC; Fung M; Seebach JD; Mollnes TE
    Transplantation; 2007 Jul; 84(2):244-50. PubMed ID: 17667817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrotype analysis and clonal characteristics of human anti-Gal alpha1-3Gal antibodies.
    Tinguely C; Schaller M; Carrel T; Nydegger UE
    Xenotransplantation; 2002 Jul; 9(4):252-9. PubMed ID: 12060461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.